Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1995
10/10/1995US5457194 Substituted aliphatic amine-containing macrocyclic immunomodulators
10/10/1995US5457129 Inhibition of nitric oxide production by retinoic acid
10/10/1995US5457125 Oxime derivatives
10/10/1995US5457038 Natural killer stimulatory factor
10/10/1995US5457034 Vectors for expression of NGF in eukaryotic cells
10/10/1995US5456924 Method of treatment of HIV-seropositive individuals with dietary whey proteins
10/10/1995US5456918 Ranitidine pharmaceutical compositions
10/10/1995US5456909 Used in therapy and diagnosis of inflammatory and immune disorders
10/10/1995CA1337297C Aminoacylates of glycerol acetal
10/05/1995WO1995026365A1 Synthetic peptide based immunogens for the treatment of allergy
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995WO1995026349A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026346A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
10/05/1995WO1995026341A1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors
10/05/1995WO1995026339A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same
10/05/1995WO1995026199A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995WO1995026134A1 Composition for inactivating irritants in fluids
10/05/1995WO1995016452A3 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
10/05/1995CA2186595A1 Synthetic peptide based immunogens for the treatment of allergy
10/05/1995CA2186496A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/04/1995EP0675136A2 Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production
10/04/1995EP0675110A1 1H-Indole-3-glyoxylamide sPLA2 inhibitors
10/04/1995EP0674902A1 Method of improving the immune response
10/04/1995EP0674651A1 Substituted 6-azaandrostenones
10/04/1995EP0674642A1 Pyrazolopyrimidines as crf antagonists
10/04/1995EP0674641A1 Pyrrolopyrimidines as crf antagonists
10/04/1995EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
10/04/1995EP0674631A1 Substituted pyrazoles as crf antagonists
10/04/1995EP0674625A1 Amino-substituted pyrazoles having crf antagonistic activity
10/04/1995EP0674624A1 Pyrazoles and pyrazolopyrimidines having crf antagonist activity
10/04/1995EP0674526A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
10/04/1995EP0674516A1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
10/04/1995EP0618905B1 Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists
10/04/1995EP0271577B1 Immunomodulating compositions and their use
10/04/1995CN1109356A Immunologic adjuvant
10/03/1995US5455265 For mammals; skin disorders, cancer, inflammatory disease, cardiovascular diorders, autoimmune diseases and others
10/03/1995US5455258 Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase
10/03/1995US5455252 Optionally substituted 6,8-quinolines
10/03/1995US5455232 Pharmaceutical preparation based on rhamnolipid
10/03/1995US5455045 High dose formulations
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
10/03/1995CA1337202C Cyclic amides which are leukotriene antagonists
10/03/1995CA1337177C Bioparyl, a biological regulator, active against various pathologies
09/1995
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025741A1 Gnrh antagonists
09/28/1995WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995WO1995025533A1 PROTEASOME REGULATION OF NF-λB ACTIVITY
09/28/1995WO1995025531A1 Means for treating auto-immune diseases and method of treatment
09/28/1995WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995WO1995023806A3 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
09/28/1995CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2185892A1 Means for treating auto-immune diseases and method of treatment
09/28/1995CA2185813A1 Vitamin-d amide derivatives
09/28/1995CA2185710A1 Gnrh antagonists
09/27/1995EP0673646A2 Use of Deoxypergualin in the manufacture of a medicament for the treatment of inflammatory-hyperresponsiveness diseases
09/27/1995EP0673426A1 Platelet-activating factor acetylhydrolase
09/27/1995EP0673421A1 Allergenic proteins and peptides from johnson grass pollen
09/27/1995EP0673420A1 Mammalian receptors for interleukin-10 (il-10)
09/27/1995EP0673367A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists
09/27/1995EP0673257A1 Low toxicity interleukin-2 analogues for use in immunotherapy
09/27/1995EP0673250A1 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis
09/27/1995EP0549621B1 New leukotriene-b4 antagonists, process for producing the same and their use as medicinal drugs
09/27/1995EP0526535B1 Cyclic hydroxamic acids and their use
09/27/1995CN1108931A Rapamycin formulations for oral administration
09/27/1995CN1108930A Soft gelatin capsule manufacture
09/26/1995US5453439 Hydroxylamine derivatives
09/26/1995US5453431 Use of hydroxychloroquine for treatment of graft-versus-host disease
09/26/1995US5453272 Serine-proline-tyrosine-glycine-arginine-cysteine hexapeptide; immunosuppressant
09/26/1995CA1337122C Pharmacologically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same
09/26/1995CA1337113C Pharmaceutical composition for eliciting an immunostimulant effect
09/21/1995WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b)
09/21/1995WO1995025124A1 Methods to diagnose and treat hiv-1 infection
09/21/1995WO1995025122A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
09/21/1995WO1995025120A1 Peptide vaccines and methods relating thereto
09/21/1995WO1995024924A1 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING α-GALACTOSYL EPITOPES
09/21/1995WO1995024923A2 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
09/21/1995WO1995024920A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/21/1995WO1995024918A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases
09/21/1995WO1995024915A1 Product and process for regulating signal transduction pathways
09/21/1995WO1995024914A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/21/1995CA2185651A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
09/21/1995CA2185534A1 Peptide vaccines and methods relating thereto
09/21/1995CA2185326A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/21/1995CA2185324A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/21/1995CA2185129A1 Methods to diagnose and treat hiv-1 infection
09/21/1995CA2184631A1 Product and process for regulating signal transduction pathways
09/20/1995EP0672411A1 Use of 2-methylamino-2-phenylcyclohexanon for the treatment of infections and as immunomodulator
09/20/1995EP0672152A1 Fusion proteins comprising mgf and il-3
09/20/1995EP0672144A1 Interleukin-6 receptor antagonists
09/20/1995EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
09/20/1995EP0672134A1 Peptides useful for inducing tolerance
09/20/1995EP0672116A1 Deletion mutants as vaccines for cholera
09/20/1995EP0672068A1 Target binding polypeptide
09/20/1995EP0672060A1 Antigen associated with type i diabetes mellitus
09/20/1995EP0672047A1 ANTIALLERGIC IMIDAZO 1,2-a](PYRROLO, THIENO OR FURANO) 2,3-d]AZEPINE DERIVATIVES
09/20/1995EP0672041A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
09/20/1995EP0672031A1 Catechol diethers as selective pde iv? inhibitors
09/20/1995EP0671952A1 Method for nonspecific cellular immune stimulation
1 ... 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 ... 1172